Key Message
Incidence, prevalence and the recurrence of CNS tumors vary according to histological type, age at diagnosis, sex, and available treatments. Further research should be performed to identify potential risk factors for CNS tumors in Saudi Arabia. Genome technology provides an opportunity to relate incidence rates with risk factors.
Citations
Citations to this article as recorded by

- Effects of Radiotherapy Alone Versus Concomitant Radiotherapy With Temozolomide Chemotherapy on the Outcome of IDH-wildtype Glioblastoma Patients
M. Kurdi, A. Alkhotani, T. Alsinani, S. Alkhayyat, Y. Katib, Z. Jastaniah, A.J. Sabbagh, N.S. Butt, F.A. Toonsi, M. Alharbi, S. Baeesa
Clinical Oncology.2025; 38: 103741. CrossRef - Epidemiology and Anatomical Distribution of Primary Brain Tumors Among Children in Palestine: A 6-Year National Referral Institution Study
Ahmad Rjoub, Wafaa Abu Zahra, Noor Issa, Yazan Dumaidi, Mohammad Abuawad, Ahmed Daqour, Abdulsalam Alkaiyat, Shahed Nasser
World Neurosurgery.2024; 186: e470. CrossRef - Epidemiology of primary brain tumor among adolescents and adults in Palestine: a retrospective study from 2018 to 2023
Mohammad Abuawad, Ahmed Daqour, Abdulsalam Alkaiyat, Ahmad Rjoub, Wafaa Abu Zahra, Noor Issa, Yazan Dumaidi, Shahed Nasser
BMC Neurology.2024;[Epub] CrossRef - Nuclear Factor-Kappa B in Gliomas as a Predictive Factor for Tumor Recurrence – A Clinicopathological Study
Basant H. Sayed, Samia M. Gabal, Ahmed M. Abdalaziz, Dalia Abd El-Kareem
Open Access Macedonian Journal of Medical Sciences.2023; 11(A): 221. CrossRef - Epidemiological Trends in Childhood Cancer in Saudi Arabia
Nazim Faisal Hamid, Fayez Muawwadh Albalawi, Abdulrahman Abdullah Aloufi, Rawapy Ali Hamas, Nasser Awadh H Alanazi, Tariq Hulayyil Alanazi
Clinical Cancer Investigation Journal.2022; 11(5): 42. CrossRef